Summary A1M Pharma AB (A1M Pharma) is a developer of a drug candidate for the diagnosis and treatment of pre-eclampsia and acute renal injury. The company offers A1M, an endogenous protein with properties that captures and eliminates toxic substances from the cells metabolism. Its A1M helps to prevent and ameliorate some of the damage caused by oxidative stress and inflammation. A1M Pharma develops novel diagnostic test for preeclampsia based on the biomarker fetal hemoglobin. The company also ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.